Tumor chemosensitivity and chemoresistance assays

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

ESMO open·2026

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.

ESMO open·2025

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

ESMO open·2025

Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Cancer·2026

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Cancer·2026

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Cancer·2026

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

Cancer·2026

CDK1-Cyclin B mediated phosphorylation of PP2A-B56 on B56Par1.T73T75 controls mitotic entry timing and Schizosaccharomyces pombe cell size.

Open biology·2026

Ventral cervical epidural electrical stimulation failed to increase respiratory activity in anesthetized humans during opioid-induced respiratory depression.

Journal of neurophysiology·2026

Co-designing opioid stewardship guidelines for cancer pain management in Nepal: study protocol.

Pain management·2026

The Ethanol-Insoluble Low-Molecular-Weight Fraction LEP-4 Derived From Lentinula edodes Mycelia Extract Attenuates Oxaliplatin-Evoked Allodynia in Mice.

Advances in pharmacological and pharmaceutical sciences·2026

Investigating the therapeutic potential of the antibacterial drug nitroxoline in combating cryptococcal infection.

PLoS neglected tropical diseases·2026

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cureus·2026

Related Experiment Videos

Tumor chemosensitivity and chemoresistance assays

Related Concept Videos

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives.

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.

A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review.

CDK1-Cyclin B mediated phosphorylation of PP2A-B56 on B56Par1.T73T75 controls mitotic entry timing and Schizosaccharomyces pombe cell size.

Ventral cervical epidural electrical stimulation failed to increase respiratory activity in anesthetized humans during opioid-induced respiratory depression.

Co-designing opioid stewardship guidelines for cancer pain management in Nepal: study protocol.

The Ethanol-Insoluble Low-Molecular-Weight Fraction LEP-4 Derived From Lentinula edodes Mycelia Extract Attenuates Oxaliplatin-Evoked Allodynia in Mice.

Investigating the therapeutic potential of the antibacterial drug nitroxoline in combating cryptococcal infection.

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Related Experiment Videos

Tumor chemosensitivity and chemoresistance assays

Related Concept Videos

Related Articles